Dec 23, 2025 · Strategically, Biocon will be one of the few companies offering both biosimilars and generics at a global scale. As the only company with biosimilar insulins and generic GLP1 peptides, …

Biocon is addressing global medical needs through a portfolio of differentiated and high quality, life saving biotherapeutics.

They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation. We have leveraged India’s value advantage of …

At Biocon, we pioneer novel approaches to improve patient outcomes today, for a better tomorrow. We constantly find new ways to treat diabetes, cancer and autoimmune diseases to improve the quality …

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon …

They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation. We have leveraged India’s value advantage of …

Biocon’s business strategy of delivering affordable innovation is well aligned with this emerging paradigm. Biocon’s fully integrated business model spans the entire drug value chain, from pre …

Biocon inaugurates Biocon Park, India's largest integrated biotechnology hub, comprising an integrated cluster of research laboratories and manufacturing facilities spread across 90 acres in KIADB …

Insulins For Domestic and Export enquiries on our Insulins range of products and related information, please write to E [email protected] Know more about us >> BioConversations >> Our Stories >> …

Jul 17, 2020 · Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based …